retatrutide vs TRIUMPH — genuinely asking which matters more
Long-ish post, sorry. tl;dr at the bottom. I have been tracking retatrutide against triglycerides for 35 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one…
Flair changed to match the content. Read the sidebar before posting next time and we are square.
You have restated the marketing copy. What is the actual substance here.
the 12.5mg arm is different from 15mg, results do not transfer
the 12.5mg arm is different from 15mg, results do not transfer
Disagree on that part. 93.7% and 99.3% on the same vial is normal.
Not to be pedantic but glucagon and triple agonist are being used interchangeably and they are not interchangeable in real life.
the dosing is steep, the reflux reports are real, and nobody knows the human safety yet
Respectfully this is a sample of one presented as a finding.
phase 2 numbers are not maintenance numbers, cite the trial
triple agonism is phase 2, do not generalise